Indaptus Therapeutics
INDP
INDP
15 hedge funds and large institutions have $6.81M invested in Indaptus Therapeutics in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
35% less capital invested
Capital invested by funds: $10.5M → $6.81M (-$3.65M)
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$153K | |
| 2 | +$108K | |
| 3 | +$78K | |
| 4 |
VCM
Vivaldi Capital Management
Chicago,
Illinois
|
+$60K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$41K |
Top Sellers
| 1 | -$800K | |
| 2 | -$217K | |
| 3 | -$16K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6.39K |